Walsh & Associates’s Elevance Health ELV Stock Holding History
Bought
Maintained
Sold
Other funds holding ELV
Walsh & Associates's ELV Position: Q3 2026 in Review
Walsh & Associates held its Elevance Health (ELV) position steady in Q3 2026 at 78 shares worth $30.3K. The position accounts for 0.02% of the portfolio, ranked #148.
Walsh & Associates first reported a position in ELV in Q4 2025 and has held it in 4 quarters since. 1,627 funds tracked by Wall St. Rank hold ELV as of Q3 2026.
- Walsh & Associates held 78 shares of Elevance Health worth $30.3K as of Q3 2026.
- Walsh & Associates left its Elevance Health share count unchanged in Q3 2026.
- Elevance Health made up 0.02% of Walsh & Associates's portfolio in Q3 2026, its #148 holding.
- Walsh & Associates first reported a position in Elevance Health in Q4 2025 and has held it in 4 quarters since.
- 1,627 funds tracked by Wall St. Rank held Elevance Health as of Q3 2026.
Based on Walsh & Associates's 13F filing for Q3 2026, filed 9 Nov 2026.